Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00204659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Primary Gastric Diffuse-Large B-Cell Lymphoma

Interventions

DRUG: Rituximab + CHOP chemotherapy

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]